This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
CAMP-dependent protein kinase 3D structures
From Proteopedia
(Difference between revisions)
| Line 16: | Line 16: | ||
*PKA catalytic subunit binary complex | *PKA catalytic subunit binary complex | ||
| - | **[[6c0u]] - hPKA + inhibitor<br /> | + | **[[6c0u]], [[7y1g]] - hPKA + inhibitor<br /> |
**[[3agl]], [[3agm]] – hPKA + bisubstrate inhibitor<br /> | **[[3agl]], [[3agm]] – hPKA + bisubstrate inhibitor<br /> | ||
**[[3bwj]] - bPKA + bisubstrate inhibitor<br /> | **[[3bwj]] - bPKA + bisubstrate inhibitor<br /> | ||
**[[1szm]] - bPKA + bisindolymaleimide<br /> | **[[1szm]] - bPKA + bisindolymaleimide<br /> | ||
**[[3ag9]] - bPKA + inhibitor<br /> | **[[3ag9]] - bPKA + inhibitor<br /> | ||
| + | **[[7lz4]] – bPKA (mutant) + CMP<br /> | ||
**[[5n1f]], [[5n1g]], [[5n1h]], [[5n3g]], [[5n3h]], [[5n3i]], [[5n3j]], [[5n3k]], [[5n3l]], [[5n3m]], [[5n3n]], [[5n3o]], [[5n3p]], [[5n3q]], [[5n3r]], [[5n3s]], [[5n3t]] - haPKA + fragment molecule<br /> | **[[5n1f]], [[5n1g]], [[5n1h]], [[5n3g]], [[5n3h]], [[5n3i]], [[5n3j]], [[5n3k]], [[5n3l]], [[5n3m]], [[5n3n]], [[5n3o]], [[5n3p]], [[5n3q]], [[5n3r]], [[5n3s]], [[5n3t]] - haPKA + fragment molecule<br /> | ||
**[[6em2]], [[6sq1]] - haPKA + drug<br /> | **[[6em2]], [[6sq1]] - haPKA + drug<br /> | ||
| Line 26: | Line 27: | ||
**[[6spy]] - haPKA + pyridine derivative<br /> | **[[6spy]] - haPKA + pyridine derivative<br /> | ||
**[[6zn0]] - haPKA + nicotinamide derivative<br /> | **[[6zn0]] - haPKA + nicotinamide derivative<br /> | ||
| + | **[[6z08]], [[7bar]] - haPKA + ligand<br /> | ||
**[[4ntt]] – mPKA (mutant) + ADP<br /> | **[[4ntt]] – mPKA (mutant) + ADP<br /> | ||
**[[1bkx]] – mPKA + adenosine<br /> | **[[1bkx]] – mPKA + adenosine<br /> | ||
| Line 73: | Line 75: | ||
**[[6i2a]] - haPKA + RPK153 + drug <br /> | **[[6i2a]] - haPKA + RPK153 + drug <br /> | ||
**[[6i2c]], [[6i2d]] - haPKA + RPK182 + drug <br /> | **[[6i2c]], [[6i2d]] - haPKA + RPK182 + drug <br /> | ||
| + | **[[7axt]], [[7axv]], [[7axw]], [[7baq]], [[7bb0]], [[7pid]], [[7pie]], [[7pif]], [[7pig]], [[7pih[[, [[7pns]] - haPKA + PKI + ligand<br /> | ||
*PKA catalytic subunit ternary complex with nucleotide | *PKA catalytic subunit ternary complex with nucleotide | ||
| Line 82: | Line 85: | ||
**[[1atp]] - mPKA + peptide inhibitor + Mn-ATP<br /> | **[[1atp]] - mPKA + peptide inhibitor + Mn-ATP<br /> | ||
**[[6e21]] - mPKA + peptide inhibitor + ADP<br /> | **[[6e21]] - mPKA + peptide inhibitor + ADP<br /> | ||
| + | **[[7e0z]], [[7e11]], [[7e12]] - mPKA + PLN peptide + PPNP<br /> | ||
**[[6em7]], [[6em6]] - haPKA + peptide inhibitor + inhibitor + ADP<br /> | **[[6em7]], [[6em6]] - haPKA + peptide inhibitor + inhibitor + ADP<br /> | ||
**[[6eh2]] - haPKA + peptide inhibitor + inhibitor + AMP<br /> | **[[6eh2]] - haPKA + peptide inhibitor + inhibitor + AMP<br /> | ||
| Line 121: | Line 125: | ||
**[[3tmh]] - rPKA II-α dimerization-anchoring domain + A-kinase anchoring protein peptide + NHERF-3<br /> | **[[3tmh]] - rPKA II-α dimerization-anchoring domain + A-kinase anchoring protein peptide + NHERF-3<br /> | ||
| + | **[[8em8]] - PfPKA + peptide + inhibitor <br /> | ||
*PKA catalytic and regulatory subunits | *PKA catalytic and regulatory subunits | ||
Revision as of 08:47, 13 November 2022
3D structures of cAMP-dependent protein kinase
Updated on 13-November-2022 {{#tree:id=OrganizedByTopic|openlevels=0|
- PKA catalytic subunit
- PKA catalytic subunit binary complex
- 6c0u, 7y1g - hPKA + inhibitor
- 3agl, 3agm – hPKA + bisubstrate inhibitor
- 3bwj - bPKA + bisubstrate inhibitor
- 1szm - bPKA + bisindolymaleimide
- 3ag9 - bPKA + inhibitor
- 7lz4 – bPKA (mutant) + CMP
- 5n1f, 5n1g, 5n1h, 5n3g, 5n3h, 5n3i, 5n3j, 5n3k, 5n3l, 5n3m, 5n3n, 5n3o, 5n3p, 5n3q, 5n3r, 5n3s, 5n3t - haPKA + fragment molecule
- 6em2, 6sq1 - haPKA + drug
- 6snn, 6snx, 6sox, 6spm, 6sps, 6spu, 6z44 - haPKA + benzoic acid derivative
- 6spy - haPKA + pyridine derivative
- 6zn0 - haPKA + nicotinamide derivative
- 6z08, 7bar - haPKA + ligand
- 4ntt – mPKA (mutant) + ADP
- 1bkx – mPKA + adenosine
- 3o7l – mPKA + phospholamban
- 1bx6, 1re8, 1rej, 1rek - mPKA + balanol analog
- 6c0u, 7y1g - hPKA + inhibitor
- PKA catalytic subunit binary complex with peptide inhibitor
- 3mvj, 3oog, 3poo, 3vqh, 5j5x, 5izj, 5izf, 5bx7, 5bx6, 4ujb, 4uja, 4uj9, 4uj2, 4uj1 - hPKA + peptide inhibitor
- 4z84, 4z83 - hPKA (mutant) + peptide inhibitor
- 2gfc, 3dnd, 3dne, 3kkv, 3zo1, 3zo2, 3zo3, 3zo4, 4ie9, 4ij9, 4yxs, 4yxr - bPKA + peptide inhibitor
- 2gng, 4axa, 4c33, 4c34, 4c35, 4c36, 4c37, 4c38 - bPKA (mutant) + peptide inhibitor
- 1cdk - pPKA + peptide inhibitor – pig
- 2cpk, 1ctp, 1fmo, 1l3r, 1xh4, 1xh5, 1xh6, 1xh7, 1xh8, 1xh9, 1xha, 3fjq, 4dg0, 4dg2, 4dh1, 4dh3, 4dh5, 4dh7, 4dh8, 4hpt, 4hpu, 4xw6, 4xw5, 4xw4, 3x2w, 3x2v, 3x2u – mPKA + peptide inhibitor
- 1q61, 1q62, 1smh, 2qur, 3qal, 3qam, 4dfx, 4dfz, 4dg3 - mPKA (mutant) + peptide inhibitor
- 4iac, 4iad, 4iaf, 4iai, 4iak, 4iay, 4iaz, 4ib0 - mPKA + PSP20 peptide
- 4ib1, 4ib3, 4o22 – mPKA + SP20 peptide
- 6mm5 – mPKA + ryanodine receptor 2 peptide
- 6mm6, 6mm7, 6mm8 – mPKA + ryanodine receptor 2 phosphorylation domain
- 4wb5, 4wb6, 4wb8 – mPKA (mutant) + PKI peptide
- 4wih, 5lcp, 5lcq, 5lcr, 5lct, 5lcu, 5m0u - haPKA + peptide inhibitor
- 6y2u, 6yna, 6ynb, 6ync, 6ynt, 6ypp, 6yqi, 6yqj, 6yqk – haPKA + PKI peptide + drug
- 6y0b, 6y2o, 6y89, 6ynr, 6yot – haPKA + PKI peptide + inhibitor
- 3mvj, 3oog, 3poo, 3vqh, 5j5x, 5izj, 5izf, 5bx7, 5bx6, 4ujb, 4uja, 4uj9, 4uj2, 4uj1 - hPKA + peptide inhibitor
- PKA catalytic subunit ternary complex
- 2gu8, 3l9l, 3ovv, 3owp, 3oxt, 3p0m, 5uzk - hPKA catalytic subunit + peptide inhibitor + inhibitor
- 3nx8 - hPKA catalytic subunit + peptide inhibitor + phenol
- 3l9m, 3l9n, 3ama, 3amb - hPKA (mutant) + peptide inhibitor + inhibitor
- 3wyg – hPKA + GSP1P + exportin
- 6qj7 – hPKA + PKI + inhibitor
- 1stc - bPKA + peptide inhibitor + saturosporine
- 2gnh, 2gni, 2gnj, 2gnl, 2jdv, 2uvx, 2uvy, 2uvz, 2uw0, 2uw3, 2uw4, 2uw5, 2uw6, 2uw7, 2uw8, 2vnw, 2vny, 2vo0, 2vo3, 2vo6, 2vo7 - bPKA (mutant) + peptide inhibitor + inhibitor
- 1ydr, 1yds, 1ydt, 2c1a, 2c1b, 2oh0, 2ojf, 2uzt, 2uzu, 2uzv, 2uzw, 2f7e, 2f7x, 2f7z, 2jds, 5vib, 6e99, 6e9l, 5vhb - bPKA + peptide inhibitor + inhibitor
- 2jdt, 5vi9 - bPKA (mutant) + peptide inhibitor + inhibitor
- 3e8c, 3e8e - bPKA catalytic subunit + peptide inhibitor + ATP-competitive inhibitor
- 1q8t, 1q8u, 1q8w- bPKA + peptide inhibitor + rho-kinase inhibitor
- 2gnf - bPKA (mutant) + peptide inhibitor + rho-kinase inhibitor
- 1sve, 1svg, 1svh, 1veb - bPKA + detergent + peptide inhibitor + azepane derivative
- 1cmk - pPKA + peptide inhibitor + myristic acid
- 3ow3 - mPKA catalytic subunit + peptide inhibitor + inhibitor
- 1apm, 1jlu - mPKA + detergent + peptide inhibitor
- 2erz - mPKA + peptide inhibitor + hydroxyfasudil
- 5mhi, 5n1d, 5n1e, 5n1k, 5n1l, 5n1m, 5n1n, 5n1o, 5n32, 5n33, 5n36, 5n37, 5n39, 5n3a, 5n3b, 5n3c, 5n3d, 5n3e, 5n3f, 5n7p, 5n7u - haPKA + peptide inhibitor + fragment molecule
- 6f14, 6frx, 6erv, 6eru, 6ert, 6i2h, 6emd, 6i2b, 6eh3, 6egw, 5ous, 5ouc, 5oua, 5otg, 5ot3, 5ol3, 5ok3, 5o5m, 5o0e, 5nw8, 5ntj - haPKA + peptide inhibitor + inhibitor
- 6erw, 6ers, 6emb, 5m75, 5m71, 5m6y, 5m6v, 5m0l, 5m0c, 5m0b - haPKA + peptide inhibitor + drug
- 6i2a - haPKA + RPK153 + drug
- 6i2c, 6i2d - haPKA + RPK182 + drug
- 7axt, 7axv, 7axw, 7baq, 7bb0, 7pid, 7pie, 7pif, 7pig, [[7pih[[, 7pns - haPKA + PKI + ligand
- 2gu8, 3l9l, 3ovv, 3owp, 3oxt, 3p0m, 5uzk - hPKA catalytic subunit + peptide inhibitor + inhibitor
- PKA catalytic subunit ternary complex with nucleotide
- 1q24 - bPKA + peptide inhibitor + Mg-ATP
- 1jbp - mPKA + detergent + peptide inhibitor + ADP
- 1rdq - mPKA + peptide inhibitor + ADP + ATP
- 4o21 - mPKA + peptide inhibitor + ATP-G-S
- 1atp - mPKA + peptide inhibitor + Mn-ATP
- 6e21 - mPKA + peptide inhibitor + ADP
- 7e0z, 7e11, 7e12 - mPKA + PLN peptide + PPNP
- 6em7, 6em6 - haPKA + peptide inhibitor + inhibitor + ADP
- 6eh2 - haPKA + peptide inhibitor + inhibitor + AMP
- 6esa - haPKA + peptide inhibitor + ribose + AMP
- 6ema - haPKA + peptide inhibitor + inhibitor + ATP
- 6y8c – haPKA + PKI peptide + ATP
- 6y05 – haPKA + PKI peptide + Adenine
- 1q24 - bPKA + peptide inhibitor + Mg-ATP
- PKA regulatory subunit
- 4f9k – hPKA I-β
- 1ne4, 1ne6, 1rl3, 3iia, 1rgs, 4mx3 - bPKA
- 2ezw - bPKA I-α dimerization-anchoring domain - NMR
- 3im3 - bPKA I-α dimerization-anchoring domain
- 3pna - bPKA I-α cAMP-binding domain
- 1cx4 - rPKA II-β cAMP-binding domain – rat
- 1r2a - mPKA II dimerization-anchoring domain – NMR
- 1l6e - mPKA II-α dimerization-anchoring domain – NMR
- 3of1, 6xqk - yPKA
- 4f9k – hPKA I-β
- PKA regulatory subunit binary complex
- 2izx, 2izy, 4zp3 - hPKA II-α + A-kinase anchoring protein peptide
- 2kyg - hPKA II-α + CBFA2T1
- 5kjx - hPKA I-α + cAMP
- 5kjy, 5kjz - hPKA I-α (mutant) + cAMP
- 3im4, 5hvz - bPKA I-α + A-kinase anchoring protein peptide
- 4jv4 – bPKA I-α + cAMP analog
- 3plq - bPKA I-α + cAMP derivative
- 2hwn - rPKA II-α + A-kinase binding peptide
- 4jva – rPKA II-β + cAMP analog
- 2drn, 2h9r - rPKA II-α dimerization-anchoring domain + A-kinase anchoring protein peptide – NMR
- 5t3n - PfPKA + cAMP derivative – Plasmodium falciparum
- 5kbf, 5k8s - PfPKA + cAMP
- 6h4g - PKA (mutant) + cAMP – Trypanosoma brucei
- 6rsx - PKA + cAMP – Euglena gracilis
- 2izx, 2izy, 4zp3 - hPKA II-α + A-kinase anchoring protein peptide
- PKA regulatory subunit ternary complex
- PKA catalytic and regulatory subunits
}}
